<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01584752</url>
  </required_header>
  <id_info>
    <org_study_id>KSSHP1U/2011</org_study_id>
    <nct_id>NCT01584752</nct_id>
  </id_info>
  <brief_title>Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas</brief_title>
  <official_title>Clinical Multicenter Study of the Efficacy of Gore-BioA Fistula Plug in High Transsphincteric Perianal Fistulas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Finland Hospital District</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Finland Hospital District</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective clinical study on the efficacy of Gore-BioA fistula plug in high
      transsphincteric fistulas. Follow-up time is six months
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria for the study is a patient with ultrasound or MRI proven high
      transsphincteric perianal fistula. Patients with Crohns disease, immunosuppressive
      medication, anovaginal fistula, radiation therapy or chemotherapy are excluded. A Seton is
      placed in the fistula track for two months before the application of the plug. Patients are
      followed up for six months. Symptoms of fecal incontinence before and after intervention are
      monitored with the Cleveland clinic incontinence score.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Healing of the fistula</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms of fecal incontinence</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Anal Fistula</condition>
  <condition>Fecal Incontinence</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Fistula patients</arm_group_label>
    <description>Gore-BioA Fistula Plug</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gore-BioA Fistula Plug</intervention_name>
    <description>Gore-BioA Fistula Plug</description>
    <arm_group_label>Fistula patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Inhabitants of Finland
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-70 years, male or female

          -  High cryptoglandular perianal fistula

          -  Written approval for the study

          -  Sufficient co-operation for the study

          -  Localization of the fistula by ultrasound or MRI

        Exclusion Criteria:

          -  Crohns disease

          -  Immunosuppressive treatment

          -  Anovaginal fistula

          -  Radiation therapy 6 months before study

          -  Chemotherapy 6 months before study

          -  Low- or intersphincteric fistula
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matti V Kairaluoma, ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Central Hospital, Jyväskylä, Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Hospital</name>
      <address>
        <city>Joensuu</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Hospital</name>
      <address>
        <city>Jyväskylä</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Hospital</name>
      <address>
        <city>Seinäjoki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2012</study_first_submitted>
  <study_first_submitted_qc>April 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2012</study_first_posted>
  <last_update_submitted>November 21, 2014</last_update_submitted>
  <last_update_submitted_qc>November 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Fecal Incontinence</mesh_term>
    <mesh_term>Rectal Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

